首页|《多维度多准则中成药综合评价技术指导原则》解读:评价指标权重

《多维度多准则中成药综合评价技术指导原则》解读:评价指标权重

Interpretation of the Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese Patent Medicine:weighting of evaluation indicators

扫码查看
原文链接
  • 维普
  • 万方数据
目的 对《多维度多准则中成药综合评价技术指导原则》中"多维度多准则中成药综合评价技术指标体系(第一版)"的权重确定方法与结果进行详细报道和解读.方法 根据层次分析法及专家赋值权重法所计算出的综合权重值进行归一化运算,获取指标的客观权重.结果 当前中成药综合评价指标体系6个一级维度权重结果显示,其权重排序为有效维度＞安全维度＞标准维度＞应用维度＞科学维度＞经济维度,权重值分别为0.281 0、0.268 5、0.195 8、0.107 3、0.096 1、0.051 3,与当前大多数研究结果一致.结论 本指标体系权重确定过程科学合理、方法明确、解读清晰,值得进一步优化研究和广泛应用.
OBJECTIVE To provide a detailed report and interpretation of the method and results for determining the weights of the technical indicators from the"multi-dimensional and multi-criteria comprehensive evaluation index system(first edition)"stated in Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese Patent Medicine.METHODS Normalization calculations were performed on the comprehensive weight values calculated by the analytic hierarchy process and expert weighting method to obtain the objective weights of the indicators.RESULTS The weight results of the six primary dimensions in the current comprehensive evaluation indicator system of Chinese patent medicine showed effectiveness dimension＞safety dimension＞standard dimension＞application dimension＞scientific dimension＞economic dimension,with weight values of 0.281 0,0.268 5,0.195 8,0.107 3,0.096 1 and 0.051 3 respectively,consistent with the results of most researches currently.CONCLUSIONS The process of weight determination in this indicator system is scientifically reasonable,with clear methods and clear interpretations,and is worthy of further optimization and widespread application.

Chinese patent medicinecomprehensive evaluationanalytic hierarchy processexpert weighting method

张海力、刘斌、王巍力、曹文杰、杨一玖、胡紫腾、陈雅馨、梁宁、李慧珍、车前子、宗星煜、陈昭、王燕平、史楠楠

展开 >

中国中医科学院中医临床基础医学研究所,北京 100700

中成药 综合评价 层次分析法 专家赋值权重法

国家自然科学基金面上项目中国中医科学院基本科研业务费新入职青年科研人员培养专项中国中医科学院科技创新工程项目国家中医药局青年岐黄学者培养项目

82174532ZZ17-ZRZ-115CI2021A00702-3国中医药人教函[2022]256号

2024

10.6039/j.issn.1001-0408.2024.07.01

中国药房
中国医院协会,中国药房杂志社

中国药房

CSTPCD北大核心
影响因子：0.956
ISSN：1001-0408
年,卷(期)：2024.35(7)
  • 15